Brief: Syros Reports Second Quarter 2023 Financial Results

Syros Pharmaceuticals

08/08/2023 13:24

Aug 8 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES
A CORPORATE UPDATE
    * SYROS PHARMACEUTICALS INC Q2 REVENUE $2.8 MILLION
    * SYROS PHARMACEUTICALS INC Q2 LOSS PER SHARE $1.30
    * SYROS PHARMACEUTICALS- EXISTING CASH, CASH EQUIVALENTS &
MARKETABLE SECURITIES SUFFICIENT TO FUND ANTICIPATED OPEX AND
CAPEX REQUIREMENTS INTO 2025

Source text for Eikon:  ID:nBw65Xc6Ba 
Further company coverage:  SYRS.O